Skip to main content

ADVERTISEMENT

Ralph G. Brindis, MD, MPH, FACC

08/01/2008
The use of risk adjustment methodology to account for patient differences in treatment outcomes is imperative to legitimately compare the results of institutions performing cardiovascular intervention. Mortality has been the most widely used...
The use of risk adjustment methodology to account for patient differences in treatment outcomes is imperative to legitimately compare the results of institutions performing cardiovascular intervention. Mortality has been the most widely used...
The use of risk adjustment...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Reports of serious injuries and deaths associated with the use of hemostasis devices1 to the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) provided the impetus for this study. These devices are...
Reports of serious injuries and deaths associated with the use of hemostasis devices1 to the Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) provided the impetus for this study. These devices are...
Reports of serious injuries and...
08/01/2008
Journal of Invasive Cardiology
08/01/2008
Reports to the Center for Devices and Radiological Health (CDRH) of the FDA regarding serious injuries and deaths associated with the use of vascular hemostasis devices1 provided the impetus for this study. These devices are used primarily to...
Reports to the Center for Devices and Radiological Health (CDRH) of the FDA regarding serious injuries and deaths associated with the use of vascular hemostasis devices1 provided the impetus for this study. These devices are used primarily to...
Reports to the Center for...
08/01/2008
Journal of Invasive Cardiology